SCIAMPA M 12.5+1000MG TAB

SCIAMPA M is a combination tablet containing Empagliflozin 12.5mg and Metformin HCL 1000mg. This dual-action formulation is designed to help manage type 2 diabetes by improving blood sugar control through two complementary mechanisms. Empagliflozin works by increasing glucose excretion through urine, while Metformin reduces glucose production in the liver and improves insulin sensitivity. Suitable for adults requiring enhanced glycemic management. Always use as directed by your healthcare provider.